Top Building Product Companies To Invest In Right Now

Dublin, Ireland-based heavy industrial manufacturer Ingersoll-Rand (NYSE: IR  ) is laying the groundwork for spinning off its Indiana-based, Ireland-registered Allegion subsidiary.

On Tuesday, Ingersoll named Quanex Building Products (NYSE: NX  ) CEO David�D. Petratis as the new chairman, president, and CEO of its soon-to-spin-off Allegion subsidiary. Petratis has served as chairman, president, and CEO of Houston-based Quanex since July 2008.

In announcing Petratis' appointment, Ingersoll-Rand CEO Michael W. Lamach called him "an accomplished leader in the manufacturing and marketing of code-compliant, high-value products that are specified by architects and engineers, and used by commercial and residential builders." Lamach also expressed hope that his "vision and leadership [will] help realize Allegion's full potential."

Based in Carmel, Ind., global security products and solutions company Allegion aims to list its shares on the New York Stock Exchange, using the ticker symbol ALLE. Post-spinoff, the company will boast $2 billion in annual sales of such products as steel doors and locks. This transaction is expected to take place by year's end.

Best Machinery Companies To Invest In Right Now: Telular Corporation(WRLS)

Telular Corporation designs, develops, and distributes products and services that utilize wireless networks to provide data and voice connectivity among people and machines primarily in the United States and internationally. It provides machine-to-machine and event monitoring services, including Telguard that comprises a specialized terminal unit, which interfaces with commercial security control panels and communicates with event processing servers to provide real-time transport of alarm signals from residential and commercial locations to an alarm company?s central monitoring station; and TankLink solution that combines a cellular communicator, wireless data services, and a Web-based application into a single offering, which allows end-users to monitor the product level in a given tank vessel. The company also offers fixed cellular terminals for voice, fax, and Internet access over the wireless networks. It sells its products to security equipment distributors, cellular carriers, and value added resellers. The company was founded in 1986 and is headquartered in Chicago, Illinois.

Advisors' Opinion:

• [By Eric Volkman]

  Telular (NASDAQ: WRLS  ) will most likely soon be an asset belonging to another company. It has entered into an agreement to be bought by private equity firm Avista Capital Partners for total consideration of $253 million. This consists of $12.61 per share in cash and roughly $18.5 million in assumed debt.

Top Building Product Companies To Invest In Right Now: Etablissements Maurel et Prom SA (MAU)

Etablissements Maurel et Prom SA is a France-based company engaged in the exploration and production of hydrocarbons (oil and gas), and in oil drilling activities. Its main activities comprise geological surveys, seismic acquisition and processing, geophysical interpretation and drilling. The Company pursues its activities mainly in Africa and Latin America, but it also has its businesses in Gabon, Senegal, Congo, Mozambique, Syria, Tanzania, Colombia, Peru, Venezuela, France and Italy. Maurel & Prom SA operates through its direct and indirect subsidiaries, including M&P Venezuela SAS, Prestoil Kouilou, Maurel & Prom Peru Holdings, Maurel & Prom Tanzanie Ltd and Panther Eureka SRL, among others. In December, 2013, the Company the acquisition of all of the shares of Caroil SAS (excluding the South American business of Caroil) from Tuscany International Drilling Inc. and has sold all of its 109,000,000 common shares of Tuscany to an entity incorporated in the Cayman Islands. Advisors' Opinion:

• [By Riddhi Kharkia]

  Since I have touched the topic of metrics, it is worthwhile to note that Twitter�� monthly active users (MAU) number stands at 57 million as compared to approximately 1.23 billion MAUs for Facebook. Monthly active user growth ticked up just 6% for Twitter on a sequential basis, while monthly active users fell 8% year over year. Even in terms of quarterly results, Facebook was miles ahead of Twitter, which was also a factor behind the sell-off in Twitter stock.

Top Building Product Companies To Invest In Right Now: ParkerVision Inc.(PRKR)

Parkervision, Inc. engages in the design, development, and sale of proprietary radio frequency (RF) technologies and products for use in semiconductor circuits for wireless communication products in the United States. The company provides its wireless technologies for processing RF waveforms in wireless applications. Its technology applies to transmit and receive functions of a radio transceiver. Its transmit portion of the technology, Direct2Power, enables the transformation of a baseband data signal to an RF carrier waveform at the desired power output level in a single unified operation. The company?s receiver portion of the technology, Direct2Data, enables the direct conversion of an RF carrier to a baseband data signal. It also provides engineering consulting and design services to its customers to assist them in developing prototypes and/or products incorporating its technologies. The company licenses its intellectual property and sells integrated circuits for incor poration into wireless devices designed by its customers. It primarily focuses on incorporating its technologies into mobile handsets, as well as to other wireless products that are related to networks serving mobile handsets, such as data cards, femtocells, and machine-to-machine and embedded applications. The company?s technology is also used in non-cellular radio applications comprising military radios. In addition, Parkervision, Inc. develops wireless radio modules for mobile handset and data card applications through a joint development and marketing agreement with LG Innotek Co., Ltd. It serves mobile handset manufacturers and their chipset suppliers in the mobile handset industry. The company was founded in 1989 and is headquartered in Jacksonville, Florida.

Advisors' Opinion:

• [By Bryan Murphy]

  I don't come hear to pat myself on the back, however. I come hear to let you know the same conditions that made American Community overbought and ripe for a reversal and suggested Real Goods Solar, Inc. was ready to rally are now saying - respectively - ParkerVision, Inc. (NASDAQ:PRKR) shares are due for a pullback and Arca Biopharma Inc. (NASDAQ:ABIO) is on the verge of a big bullish thrust.

Top Building Product Companies To Invest In Right Now: ChinaCache International Holdings Ltd.(CCIH)

ChinaCache International Holdings Ltd. provides Internet content and application delivery services to businesses, government agencies, and enterprises in China. It offers Web Page Content Services to website operators; file transfer services; rich media streaming services that enable live streaming of media files; guaranteed application services for websites that incorporate applications with features, such as on-line booking and ordering, real-time stock quotes, and on-line surveys; managed internet data services; ChinaCache cloud services; and content bridging services. The company also provides various value-added services, such as geo-content acceleration services, performance evaluation module, scalable services routing services, link anti-hijack services, NetStorage services, user behavior analysis services, and Website performance evaluation services. The company was founded in 1998 and is headquartered in Beijing, the People?s Republic of China.

Advisors' Opinion:

• [By Garrett Cook]

  Technology shares fell around 0.27 percent in Thursday’s trading. Top decliners in the sector included TechTarget (NASDAQ: TTGT), down 5.3 percent, and ChinaCache International Holdings (NASDAQ: CCIH), off 2.11 percent.

• [By Garrett Cook]

  Technology shares fell around 0.27 percent in Thursday’s trading. Top decliners in the sector included TechTarget (NASDAQ: TTGT), down 8.9 percent, and ChinaCache International Holdings (NASDAQ: CCIH), off 4.6 percent.

Top Building Product Companies To Invest In Right Now: Enel SpA (ENEL)

Enel SpA is an Italy-based company engaged in the utilities sectors. It operates in seven divisions. The Sales segment focuses on the sale of electricity and gas products and services for end users. The Generation and Energy Management is involved in generation with thermal, natural gas regasification and schedulable hydroelectric power plants. The Infrastructure and Networks distributes electricity and public lighting. The Iberia and Latin America operates in the electricity and gas markets of Spain, Portugal and Latin America. The International segment supports strategies for the European and Russian markets. The Renewable Energy is active in the generation of electricity from renewable resources. The Engineering and Research develops the conventional and nuclear construction of power plants. In November 2013, through Enel Investment Holding BV, it sold a 40% stake in Artic Russia BV, which in turn owns a 49% of the share capital of SeverEnergia, to NK Rosneft' OAO. Advisors' Opinion:

• [By Jonathan Morgan]

  Enel SpA (ENEL) retreated 3.8 percent to 3.22 euros after Deutsche Bank AG said that its estimates for earnings at Italy�� biggest utility show no potential for growth for 2013 or 2014.

Top Building Product Companies To Invest In Right Now: Cbeyond Inc.(CBEY)

Cbeyond, Inc. provides managed information technology (IT) and communications services to small businesses in the United States. Its services include local and long-distance voice, broadband Internet, mobile services, broadband laptop access, voicemail, email, Web hosting, fax-to-email, data backup, file-sharing, virtual private networking, and cloud servers; and cloud applications, data center infrastructure as a service, cloud private branch exchange phone systems, metro Ethernet, multi-protocol label switching, information security, administration management, and professional services to migrate and manage customer environments. It sells its products and services through direct sales; value-added resellers, local area network consultants, and other IT and communications consultants; and managed services providers, systems integrators, and software vendors. The company was formerly known as Cbeyond Communications, Inc. and changed its name to Cbeyond, Inc. in July 2006. Cbeyond, Inc. was founded in 2000 and is headquartered in Atlanta, Georgia.

Advisors' Opinion:

• [By Lisa Levin]

  Cbeyond (NASDAQ: CBEY) shares reached a new 52-week low of $6.07. Cbeyond's PEG ratio is -1.19.

  Swisher Hygiene (NASDAQ: SWSH) shares touched a new 52-week low of $0.732. Swisher Hygiene appointed William Pierce as its new president and CEO.

• [By Lisa Levin]

  Cbeyond (NASDAQ: CBEY) shares gained 38.56% to touch a new 52-week high of $9.81 after the company agreed to be acquired by Birch Communications in all-cash transaction valued at $323 million.

Top Building Product Companies To Invest In Right Now: Epizyme Inc (EPZM)

Epizyme, Inc., incorporated on November 1, 2007, is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers. The Company systematically identify the genetic alterations that create cancer causing genes, called oncogenes, select patients in whom the identified genetic alteration is found and then design small molecule therapeutics to inhibit the oncogene. The clinical development plan for each of its product candidates is directed towards patients with a particular genetically defined cancer.The Company is conducting a Phase I clinical trial of its advanced product candidate, EPZ-5676, an inhibitor targeting the DOT1L HMT, for the treatment of mixed lineage leukemia (MLL-r). The Company has identified its two lead product candidates using its product platform.

EPZ-5676-DOT1L Inhibitor

EPZ-5676 is an intravenously administered small molecule inhibitor of DOT1L. The Company is developing EPZ-5676 for the treatment of MLL-r, an aggressive subtype of the two most common forms of acute leukemia, ALL and AML. Patients with MLL-r are routinely diagnosed with existing technologies that are commonly used in clinical setting. The Company�� Phase 1 clinical trial of EPZ-5676 is an open label, multicenter trial that has two phases.

EPZ-6438-EZH2 Inhibitor

The Company is developing EPZ-6438 as an orally available small molecule inhibitor of EZH2 for the treatment of non-Hodgkin lymphoma patients who have an oncogenic point mutation in EZH2. EZH2 is an HMT that can become oncogenic and cause non-Hodgkin lymphoma and a range of other solid tumors. Two types of non-Hodgkin lymphoma, diffuse large B-cell lymphoma of germinal-center origin, or DLBCL, and follicular lymphoma, or FL, are particularly associated with an EZH2 point mutation. There are no therapies approved specifically for the treatment of cancer associated with an EZH2 point mutation.

Advisors' Opinion:

• [By John Udovich]
  Follow-on Stock Offerings From Small Cap Biotech Stocks. Thanks to the boom in biotech IPOs along with the sector�� overall performance, already listed biotechs have the option to ask investors for more cash in the form of a follow-on offering. Recently, FierceBiotech.com noted how four small cap biotechs raised $276 million from follow-on offerings in just one day last week. These small caps�included Epizyme Inc (NASDAQ: EPZM) which raised $88 million, Halozyme Therapeutics, Inc (NASDAQ: HALO) which raised $100 million, Agenus Inc (NASDAQ: AGEN) which raised $52 million and Idera Pharmaceuticals Inc (NASDAQ: IDRA) which raised $36 million. FierceBiotech.com noted that the�steady flow of about $4.5 billion a year in venture cash�along with�more than $3.5 billion from IPOs last year plus all of the�follow-ons are helping to foster both company growth and�accelerate drug�development programs. Mixed Bag for Biotech IPOs. Last Wednesday also saw two small cap biotech IPOs fizzle in one day�with small cap T cell vaccine developer�Genocea Biosciences Inc (NASDAQ: GNCA) raising $60 million but then ending the day down 8.3% to close at $11 while Dutch drug developer uniQure NV (QURE) raised $81.9 million but fell more than 14% to $14.61. However, orphan drug stock Auspex Pharmaceuticals Inc (NASDAQ: ASPX), which is developing�drugs to treat orphan diseases like Tourette syndrome, saw a 30.5% gain to close at $15.66 and raise $84 million. The Boston Globe quoted Michael Ringel, a partner and managing director at Boston Consulting Group who focuses on health care business, as saying:

  ��he mood is incredibly positive. Capital is flowing. [The biotech IPOs]��have been burning hot. I think it�� too early to suggest that is changing. I can�� predict the overall economy any better than anyone else, but I would expect a pretty good year for IPOs.��/p>

• [By Dan Caplinger]

  Outside the Dow, there were a few winners. Guess? (NYSE: GES  ) climbed 8% after a better-than-expected earnings performance, despite the fact that profits fell from year-ago levels. The retailer repeated what we've heard from its peers about bad weather conditions having a negative impact on the company, and its European operations also struggled. Meanwhile, biotech IPO Epizyme (NASDAQ: EPZM  ) soared more than 50% after coming public at $15 this morning. The company has a promising technology in treating cancer caused by carcinogenic genes, and it has collaborations with several major drug companies that should help it push some of its potential treatments through the pipeline.

• [By John Udovich]

  It�� a new year and the first one and a half trading weeks of 2014 has not disappointed biotech investors as the sector and mid cap or small cap biotech or�pharma stocks like Intercept Pharmaceuticals Inc (NASDAQ: ICPT), Epizyme Inc (NASDAQ: EPZM), Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) and TNI BioTech Inc (OTCQB: TNIB) either surging or producing some news plus there have been IPO filings for future listings for�Flexion Therapeutics (NASDAQ: FLXN), Aldexa Therapeutics (NASDAQ: ALDX), Retrophin (NASDAQ:�RTRX) and Dicerna Pharmaceuticals (NASDAQ: DRNA). Consider the following news so far this year:

• [By Laura Brodbeck]

  Friday

  Earnings Expected From: Epizyme (NASDAQ: EPZM), Dyax Corp (NASDAQ: DYAX) Economic Releases Expected: ��German GDP, German business climate index, Italian retail sales.

  Get all the #premarket info by listening in to Benzinga's morning show at 8:00 am EST Monday-Friday!